Aimei Health Technology Co., Ltd is projected to rise to $45.67 by 2027, a +1% move from its current price of $45.32. AFJK is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $42.59 | $45.31 | $48.21 | -0.02% |
| May 30 | $41.50 | $45.30 | $49.45 | -0.05% |
| May 31 | $40.68 | $45.29 | $50.42 | -0.07% |
| Jun 1 | $40.00 | $45.28 | $51.26 | -0.09% |
| Jun 2 | $39.41 | $45.27 | $52.00 | -0.11% |
| Jun 3 | $38.88 | $45.26 | $52.68 | -0.14% |
| Jun 4 | $38.40 | $45.25 | $53.32 | -0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $38.40 | $45.25 | $53.32 | -0.16% |
| Week 2 | $35.82 | $45.18 | $56.97 | -0.32% |
| Week 3 | $33.95 | $45.10 | $59.93 | -0.48% |
| Week 4 | $32.43 | $45.03 | $62.52 | -0.64% |
| Week 5 | $31.15 | $44.96 | $64.89 | -0.79% |
| Week 6 | $30.03 | $44.89 | $67.09 | -0.95% |
| Week 7 | $29.03 | $44.82 | $69.18 | -1.11% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aimei Health Technology Co., Ltd (AFJK) is described as a Financial Services company based in New York, New York. The company was incorporated in 2023 and, as stated, does not have significant operations.
The description also notes an intent to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It plans to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector.
This framing places AFJK in a period focused on potential corporate transactions and strategic acquisitions rather than routine operating activity.”}{
AFJK trades at $45.32 and sits in the Financial Services sector with a market capitalization of $143.5M. It is currently ranked 4002 by market cap.
The forecast pathway shows a range of potential outcomes by year, with the 2026 average near the current level and later years showing upside and volatility. Long-range milestones include a 2040 average around $91.01 and a 2050 average near $127.56, suggesting meaningful upside in the outer years while acknowledging year-to-year variability.
Overall, the outlook indicates potential upside over the long horizon, alongside notable uncertainty and sensitivity to yearly conditions.”}{
A major floor 46.2% below — a decisive break under it would weaken the trend.
The nearest floor, 11.7% below — buyers have tended to step in here.
The nearest ceiling, 13.0% above — a clean break opens room to run.
A major ceiling 49.7% above — clearing it would confirm fresh momentum.
Key AFJK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AFJK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $41.61 | Buy | $42.18 | Buy |
| MA 10 | $41.36 | Buy | $42.01 | Buy |
| MA 20 | $42.84 | Buy | $42.17 | Buy |
| MA 50 | $38.97 | Buy | $40.85 | Buy |
| MA 100 | $42.90 | Buy | $38.27 | Buy |
| MA 200 | $29.76 | Buy | $32.26 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.98 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 93.00 | Neutral |
| Williams %R (14) | -0.37 | Info |
| MACD (12,26,9) | -0.26 | Sell |
| ROC (12) | 6.21 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 99.63 | Sell |
| TRIX (15) | 0.16 | Buy |
| Awesome (5,34) | -3.35 | Sell |
| Ultimate (7,14,28) | 63.78 | Neutral |
| Momentum (10) | 2.83 | Buy |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 41.39 | Buy |
| ADX (14) | 8.72 | Neutral |
| ATR (14) | 1.87 | Info |
The 30-day technical picture is bullish, with sentiment labeled BULLISH and an RSI(14) of 60.
Prices are trading above the SMA50 of $38.97 and the SMA200 of $29.76, indicating constructive near-term momentum. Key near-term levels include support at $40.00 and resistance at $51.20, framing a plausible range for the next month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $24.37 | $45.32 | $63.39 | 0% | Neutral | |
| $32.86 | $45.67 | $68.67 | +1% | Neutral | |
| $24.19 | $35.67 | $57.02 | -21% | Bearish | |
| $26.20 | $40.66 | $68.15 | -10% | Neutral | |
| $25.84 | $42.03 | $73.28 | -7% | Neutral | |
| $26.40 | $44.86 | $80.91 | -1% | Neutral | |
| $34.65 | $61.42 | $114.17 | +36% | Bullish | |
| $34.28 | $63.26 | $120.83 | +40% | Bullish | |
| $32.13 | $61.67 | $120.73 | +36% | Bullish | |
| $30.08 | $60.02 | $120.21 | +32% | Bullish | |
| $40.96 | $91.01 | $200.19 | +101% | Bullish | |
| $57.40 | $127.56 | $293.39 | +181% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $24.37 | $45.32 | $54.15 | +0.00% |
| June 2026 | $38.73 | $46.45 | $57.72 | +2.49% |
| July 2026 | $36.39 | $44.39 | $56.57 | -4.44% |
| August 2026 | $36.14 | $44.67 | $58.04 | +0.64% |
| September 2026 | $37.98 | $47.46 | $62.63 | +6.25% |
| October 2026 | $37.47 | $47.31 | $63.31 | -0.33% |
| November 2026 | $35.64 | $45.40 | $61.50 | -4.02% |
| December 2026 | $36.00 | $46.27 | $63.39 | +1.90% |
Click any year to see its month-by-month AFJK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, AFJK could reach as high as $63.39, with a base case around $45.32 and support toward $24.37 — roughly 0% from $45.32. A consolidation phase looks the most probable path here.
Expect AFJK to range from $32.86 to $68.67 through 2027. The $45.67 average target implies a +1% move from current prices. That is up +1% on the projected 2026 average. Price action looks broadly range-bound.
The AFJK price prediction for 2028 points to an average of $35.67 (low $24.19, high $57.02) — a potential decline of -21% on today's $45.32. Expect choppier, lower action through this leg of the cycle.
In 2029, AFJK is projected to trade between $26.20 and $68.15, averaging $40.66 — a potential decline of -10% from today's $45.32. That is up +14% on the projected 2028 average. Price action looks broadly range-bound.
Aimei Health Technology Co., Ltd's 2030 outlook centres on $42.03, within a $25.84 to $73.28 range. That is up +3% on the projected 2029 average. That marks a -7% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, AFJK could reach as high as $80.91, with a base case around $44.86 and support toward $26.40 — roughly -1% from $45.32. Price action looks broadly range-bound.
Expect AFJK to range from $34.65 to $114.17 through 2032. The $61.42 average target implies a +36% move from current prices. That is up +37% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The AFJK price prediction for 2033 points to an average of $63.26 (low $34.28, high $120.83) — a potential gain of +40% on today's $45.32. Momentum favours further upside here.
In 2034, AFJK is projected to trade between $32.13 and $120.73, averaging $61.67 — a potential gain of +36% from today's $45.32. That is -3% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
Aimei Health Technology Co., Ltd's 2035 outlook centres on $60.02, within a $30.08 to $120.21 range. That is -3% versus the projected 2034 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2040, AFJK could reach as high as $200.19, with a base case around $91.01 and support toward $40.96 — roughly +101% from $45.32. Buyers look set to stay in control over this stretch.
Expect AFJK to range from $57.40 to $293.39 through 2050. The $127.56 average target implies a +181% move from current prices. That is up +40% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in AFJK today (≈ 22.065313 AFJK) could be worth
$2,814.63
+$1,814.63 (+181%) by 2050 · US Dollar
Based on the average projected AFJK price of $127.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AFJKwould be worth at today's price.
$1,000 invested in AFJK on May 27, 2025 (≈ 89.525514 AFJK) would be worth
$4,057.3
+$3,057.3 (+305.7%) today · 4.06× · US Dollar
Based on a AFJK entry price of $11.17 vs. today's $45.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $42.17 | $1,074.57 | +7.5% |
| 1 month ago | $44.89 | $1,009.58 | +1.0% |
| 3 months ago | $32.31 | $1,402.66 | +40.3% |
| 6 months ago | $10.65 | $4,255.4 | +325.5% |
| 1 year ago | $11.17 | $4,057.3 | +305.7% |
| All time (2.3y) ago | $10.15 | $4,465.02 | +346.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AFJK forecast.
Our base-case forecast reaches $91.00 around 2040.
Implied market cap at $91.00: $288.14M
In the multi-year forecast, the 2026 average price is $45.32 with a min of $24.37 and a max of $63.39, and a Neutral sentiment. The recorded ROI for 2026 is 0, reflecting a flat near-term outlook.
For 2030, the average price is $42.03 with a min of $25.84 and a max of $73.28; the ROI is -7.3 and sentiment is Neutral, indicating modest downside risk relative to the current level.
The long-range view shows bullish momentum emerging in later years, with 2040 averaging $91.01 and a max of $200.19, yielding a 100.8% ROI. The 2050 forecast is even more elevated, with an average of $127.56, a max of $293.39, and a 181.5% ROI, both cases labeled BULLISH.
Tap a question to reveal the answer.
Avg $42.03; Min $25.84; Max $73.28; ROI -7.3; Sentiment NEUTRAL.
Forecasts show NEUTRAL in 2026 and 2027, then Bearish in 2028 and 2029, Neutral again in 2030 and 2031, and Bullish from 2032 onward, with notable ROIs: -7.3 in 2030; 100.8 in 2040; 181.5 in 2050.
Yes. The 2030 max is $73.28, with higher maxima in subsequent years: 2031 $80.91, 2032 $114.17, 2033 $120.83, 2040 $200.19, and 2050 $293.39.
Sentiment BULLISH; RSI(14) 60; SMA50 $38.97; SMA200 $29.76; support $40.00; resistance $51.20; 30-day range $30.11-$68.21; annualized volatility 100%.
Current price $45.32; market cap $143.5M; rank 4002.
Aimei Health Technology Co., Ltd Community Discussion
0Share your Aimei Health Technology Co., Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.